{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Athira Pharma, Inc."},"Symbol":{"label":"Symbol","value":"ATHA"},"Address":{"label":"Address","value":"18706 NORTH CREEK PARKWAY,SUITE 104, BOTHELL, Washington, 98011, United States"},"Phone":{"label":"Phone","value":"+1 425 620-8501"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease."},"CompanyUrl":{"label":"Company Url","value":"https://www.athira.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Javier San Martin","title":"Chief Medical Officer"},{"name":"Kevin Church","title":"Chief Scientific Officer"},{"name":"Mark J. Litton","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}